ConductScience.org, home

Paper42852014PubMed

Reassessing Viral Gene Therapy for Glioblastoma: Translational Opportunities and Challenges.

Madani J and 2 others. Yale J Biol Med, 2026.

Cite this record

ConductScience Library. Reassessing Viral Gene Therapy for Glioblastoma: Translational Opportunities and Challenges. Papers, record 42852014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42852014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reassessing Viral Gene Therapy for Glioblastoma: Translational Opportunities and Challenges.
Journal
Yale J Biol Med
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-13

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Madani JJadhttps://orcid.org/0009-0009-9908-063X
2Vellani ZZaid
3Fayed YYousef

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Genetic TherapyMajor topic
GlioblastomaMajor topic
Translational Research, BiomedicalMajor topic
Animals
Humans
CRISPR-Cas Systems
Gene Therapy Agents
Oncolytic Virotherapy
Oncolytic Viruses

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136428586Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.Cancers (Basel)2022https://conductscience.org/library/papers/36428586PubMed
238267500Identification of genes with oscillatory expression in glioblastoma: the paradigm of SOX2.Sci Rep2024https://conductscience.org/library/papers/38267500PubMed
324294541Suicide Gene Therapy for Cancer - Current Strategies.J Genet Syndr Gene Ther2013https://conductscience.org/library/papers/24294541PubMed
440745004Applications of multiplexed CRISPR-Cas for genome engineering.Exp Mol Med2025https://conductscience.org/library/papers/40745004PubMed
536970624Off-target effects in CRISPR/Cas9 gene editing.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/36970624PubMed
641063230New experimental therapies for glioblastoma: a review of preclinical research.Acta Neuropathol Commun2025https://conductscience.org/library/papers/41063230PubMed
729668458On the Concepts and History of Glioblastoma Multiforme - Morphology, Genetics and Epigenetics.Folia Med (Plovdiv)2018https://conductscience.org/library/papers/29668458PubMed
838275409CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review.Biomedicines2024https://conductscience.org/library/papers/38275409PubMed
926072401Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis.Methods Mol Biol2015https://conductscience.org/library/papers/26072401PubMed
1037245011
Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial.
J Transl Med2023https://conductscience.org/library/papers/37245011PubMed
1135689624Epigenetic features drastically impact CRISPR-Cas9 efficacy in plants.Plant Physiol2022https://conductscience.org/library/papers/35689624PubMed
1230627060Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.Contrast Media Mol Imaging2018https://conductscience.org/library/papers/30627060PubMed
1336823172Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.Nat Commun2023https://conductscience.org/library/papers/36823172PubMed
1439752252Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.Cell Rep2025https://conductscience.org/library/papers/39752252PubMed
1511353831Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11353831PubMed
1635864254Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med2022https://conductscience.org/library/papers/35864254PubMed
1719098898Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.Nat Biotechnol2009https://conductscience.org/library/papers/19098898PubMed
1838720342Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.J Hematol Oncol2024https://conductscience.org/library/papers/38720342PubMed
1928798809Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy.Ecancermedicalscience2017https://conductscience.org/library/papers/28798809PubMed
2031750274Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.Oncolytic Virother2019https://conductscience.org/library/papers/31750274PubMed

See all 47 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42852014

GET https://conductscience.org/api/papers/v1/42852014/references?page=2